100 related articles for article (PubMed ID: 28453877)
1. Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with Type 1 diabetes.
McAuley SA; Ward GM; Horsburgh JC; Gooley JL; Jenkins AJ; MacIsaac RJ; O'Neal DN
Diabet Med; 2017 Aug; 34(8):1158-1164. PubMed ID: 28453877
[TBL] [Abstract][Full Text] [Related]
2. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
3. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study.
McAuley SA; Horsburgh JC; Ward GM; La Gerche A; Gooley JL; Jenkins AJ; MacIsaac RJ; O'Neal DN
Diabetologia; 2016 Aug; 59(8):1636-44. PubMed ID: 27168135
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial.
Ruan Y; Elleri D; Allen JM; Tauschmann M; Wilinska ME; Dunger DB; Hovorka R
Diabetologia; 2015 Apr; 58(4):687-90. PubMed ID: 25537835
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
[TBL] [Abstract][Full Text] [Related]
6. Algorithm that delivers an individualized rapid-acting insulin dose after morning resistance exercise counters post-exercise hyperglycaemia in people with Type 1 diabetes.
Turner D; Luzio S; Gray BJ; Bain SC; Hanley S; Richards A; Rhydderch DC; Martin R; Campbell MD; Kilduff LP; West DJ; Bracken RM
Diabet Med; 2016 Apr; 33(4):506-10. PubMed ID: 26220149
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
8. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
Franc S; Daoudi A; Pochat A; Petit MH; Randazzo C; Petit C; Duclos M; Penfornis A; Pussard E; Not D; Heyman E; Koukoui F; Simon C; Charpentier G
Diabetes Obes Metab; 2015 Dec; 17(12):1150-7. PubMed ID: 26264812
[TBL] [Abstract][Full Text] [Related]
9. Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial.
Heise T; Bain SC; Bracken RM; Zijlstra E; Nosek L; Stender-Petersen K; Rabøl R; Rowe E; Haahr HL
Diabetes Obes Metab; 2016 Feb; 18(2):196-9. PubMed ID: 26450456
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.
Heise T; Stender-Petersen K; Hövelmann U; Jacobsen JB; Nosek L; Zijlstra E; Haahr H
Clin Pharmacokinet; 2017 Jun; 56(6):649-660. PubMed ID: 27878566
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
[TBL] [Abstract][Full Text] [Related]
12. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
13. Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device.
Landau Z; Klonoff D; Nayberg I; Feldman D; Levit SB; Lender D; Mosenzon O; Raz I; Wainstein J
Diabetes Metab Res Rev; 2014 Nov; 30(8):686-92. PubMed ID: 24610683
[TBL] [Abstract][Full Text] [Related]
14. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart.
Heise T; Hövelmann U; Brøndsted L; Adrian CL; Nosek L; Haahr H
Diabetes Obes Metab; 2015 Jul; 17(7):682-8. PubMed ID: 25846340
[TBL] [Abstract][Full Text] [Related]
15. Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.
Kristensen PL; Tarnow L; Bay C; Nørgaard K; Jensen T; Parving HH; Perrild H; Beck-Nielsen H; Christiansen JS; Thorsteinsson B; Pedersen-Bjergaard U
Diabet Med; 2017 May; 34(5):625-631. PubMed ID: 28099755
[TBL] [Abstract][Full Text] [Related]
16. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.
Cengiz E; Weinzimer SA; Sherr JL; Tichy E; Martin M; Carria L; Steffen A; Tamborlane WV
Pediatr Diabetes; 2013 May; 14(3):168-73. PubMed ID: 23107353
[TBL] [Abstract][Full Text] [Related]
17. Faster Insulin Aspart: A New Bolus Option for Diabetes Mellitus.
Davis A; Kuriakose J; Clements JN
Clin Pharmacokinet; 2019 Apr; 58(4):421-430. PubMed ID: 29978361
[TBL] [Abstract][Full Text] [Related]
18. Fiasp--another insulin aspart formulation for diabetes.
Med Lett Drugs Ther; 2018 Jan; 60(1537):6-7. PubMed ID: 29294464
[No Abstract] [Full Text] [Related]
19. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
20. Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
Laimer M; Melmer A; Mader JK; Schütz-Fuhrmann I; Engels HR; Götz G; Pfeifer M; Hermann JM; Stettler C; Holl RW
PLoS One; 2016; 11(3):e0150604. PubMed ID: 26938444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
